Stockscreener 앱 받기
48.36
5.01%
-2.55
시간 외 거래:
48.32
-0.04
-0.08%
전일 마감가:
$50.91
열려 있는:
$50.02
하루 거래량:
3.85M
Relative Volume:
1.55
시가총액:
$7.57B
수익:
$1.22B
순이익/손실:
$81.07M
주가수익비율:
94.07
EPS:
0.5141
순현금흐름:
$223.02M
1주 성능:
-12.10%
1개월 성능:
-12.41%
6개월 성능:
-15.76%
1년 성능:
-2.85%
1일 변동 폭
$47.85
$50.50
1주일 범위
$45.12
$57.01
52주 변동 폭
$45.12
$72.16
바이오-테크네 Stock (TECH) Company Profile
명칭
Bio Techne Corp
전화
612-379-8854
주소
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Compare TECH vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
48.36 | 7.97B | 1.22B | 81.07M | 223.02M | 0.5141 |
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.87B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
714.89 | 74.34B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
782.17 | 48.96B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.05 | 39.51B | 4.29B | 577.22M | 641.34M | 4.2086 |
ONC
Beone Medicines Ltd Adr
|
312.12 | 32.89B | 5.36B | 287.73M | 924.18M | 2.5229 |
바이오-테크네 Stock (TECH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2025-07-09 | 개시 | TD Cowen | Buy |
| 2025-05-30 | 개시 | Wells Fargo | Overweight |
| 2025-04-09 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-08 | 개시 | Scotiabank | Sector Outperform |
| 2024-02-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-08-28 | 개시 | William Blair | Outperform |
| 2023-01-10 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | 업그레이드 | Stifel | Hold → Buy |
| 2021-01-25 | 재확인 | The Benchmark Company | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-07-15 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-05-14 | 개시 | The Benchmark Company | Buy |
| 2020-01-08 | 재개 | Stephens | Overweight |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-02 | 업그레이드 | Janney | Neutral → Buy |
| 2019-01-14 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-10-17 | 개시 | Goldman | Neutral |
| 2018-06-15 | 개시 | Argus | Buy |
| 2017-07-13 | 개시 | Wells Fargo | Market Perform |
| 2017-02-09 | 개시 | Citigroup | Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Buy |
| 2016-11-10 | 재개 | Leerink Partners | Outperform |
| 2015-01-21 | 재확인 | Robert W. Baird | Outperform |
| 2013-09-20 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
모두보기
바이오-테크네 주식(TECH)의 최신 뉴스
TECH (TECH) Form 144 shows planned option-exercise sales, prior sale by Molho - Stock Titan
Earnings call transcript: Bio-Techne Q3 2026 results show strategic focus - Investing.com Australia
Rep. April McClain Delaney Sells Bio-Techne Corp (NASDAQ:TECH) Shares - MarketBeat
April McClain Delaney Makes Significant Trades in Bio-Techne Corp, C.H. Robinson Worldwide, and Transdigm Group - Investing.com UK
Evercore Maintains Bio-Techne(TECH.US) With Hold Rating, Cuts Target Price to $50 - Moomoo
CFO at Bio-Techne (TECH) exercises 62,000 options and settles taxes in shares - Stock Titan
Bio-Techne (TECH) SVP exercises 8,400 options, 7,055 shares withheld for taxes - Stock Titan
Bio-Techne (TECH) CEO exercises options; shares withheld for taxes - Stock Titan
Citigroup Issues Pessimistic Forecast for Bio-Techne (NASDAQ:TECH) Stock Price - MarketBeat
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
Wells Fargo & Company Cuts Bio-Techne (NASDAQ:TECH) Price Target to $62.00 - MarketBeat
Bio-Techne Corporation (NASDAQ:TECH) Q3 2026 Earnings Call Transcript - Insider Monkey
Bio-Techne Q3 Earnings Call Highlights - Yahoo Finance
Bio-Techne Leads Key Proteomic Reagent Markets, but Near-Term Challenges Loom - Morningstar
Bio-Techne (NASDAQ:TECH) Hits New 52-Week Low After Earnings Miss - MarketBeat
Bio-Techne Corp (NASDAQ:TECH) to Issue Quarterly Dividend of $0.08 - MarketBeat
Why Bio-Techne (TECH) Is Up 5.9% After Profits Rose Despite Slightly Lower Sales – And What's Next - Yahoo Finance
Bio-Techne Corporation Q3 2026 Earnings Call Summary - Yahoo Finance
Bio-Techne (NASDAQ: TECH) grows profit despite softer March-quarter sales - Stock Titan
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Bio-Techne stock hits 52-week low at 46.04 USD By Investing.com - Investing.com Canada
Bio-Techne (NASDAQ:TECH) Posts Quarterly Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Bio-Techne stock hits 52-week low at 46.04 USD - Investing.com
S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today - Benzinga
Earnings call transcript: Bio-Techne Q3 2026 results disappoint investors By Investing.com - Investing.com South Africa
Bio-Techne slides after fiscal Q3 results show revenue decline and a miss versus consensus estimates - Quiver Quantitative
TECH Stock Falls on Q3 Earnings & Revenue Miss, Operating Margin Up - Yahoo Finance UK
Bio-Techne (NASDAQ:TECH) Shares Down 10.8% on Disappointing Earnings - MarketBeat
FMR LLC reports 5.0% ownership in Bio‑Techne Corp (NASDAQ: TECH) via 13G - Stock Titan
Bio-Techne Q3 2026 Earnings Call: Complete Transcript - Benzinga
Bio-Techne (NASDAQ:TECH) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings - Yahoo Finance
Bio-Techne Corp (NASDAQ:TECH) Slides as Q3 Earnings and Revenue Miss Estimates - ChartMill
Bio-Techne declares $0.08 quarterly dividend - Investing.com
BIO-TECHNE ($TECH) Releases Q3 2026 Earnings - Quiver Quantitative
Bio-Techne declares $0.08 quarterly dividend By Investing.com - Investing.com Canada
Bio-Techne will pay shareholders 8 cents a share on May 29 - Stock Titan
Bio-Techne profit nearly doubles even as sales slip to $311.4M - Stock Titan
Bio-Techne (NASDAQ: TECH) posts Q3 2026 results and $0.08 dividend - Stock Titan
Bio-Techne sets 8 a.m. May 6 webcast for fiscal Q3 results - Stock Titan
Bio-Techne (TECH) executive nets shares from 794 RSU exercise - Stock Titan
Investors brace for Bio-Techne earnings amid muted outlook By Investing.com - Investing.com Nigeria
TECH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Bio-Techne CEO Kim Kelderman to speak at BofA healthcare event - Stock Titan
Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference - ChartMill
Bio-Techne Corp (TECH) Stock Analysis: Evaluating a 31.36% Potential Upside in the Biotechnology Sector - DirectorsTalk Interviews
MSN Money - MSN
Vanguard Group Inc. Sells 121,495 Shares of Bio-Techne Corp $TECH - MarketBeat
UBS Group AG Raises Position in Bio-Techne Corp $TECH - MarketBeat
Conestoga Capital Advisors LLC Boosts Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Comerica Bank Increases Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock underperforms Thursday when compared to competitors - MSN
바이오-테크네 (TECH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
11.97%
3.48%
자본화:
|
볼륨(24시간):